Accelerate to discover
Related topics
Imaging Performance of a multimodal module to enhance preclinical irradiator capabilities
Sep 15, 2020
Upgrading an existing irradiator with such a multi-modal imaging device is a reasonable investment in laboratories...
Are you still using traditional methodologies for your Oncology cell metabolism studies?
Sep 10, 2020
In this infographic, learn about the challenges experienced by scientists in analysing cellular metabolism and how...
Using DNA repair and machine learning to improve cancer risk prediction
Sep 7, 2020
Across the world, breast cancer continues to be the leading type of cancer in women, accounting for 25% of all cases....
Quantitative evaluation of pulmonary function with hyperpolarized xenon gas MR
Aug 20, 2020
Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...
Get more out of your full spectrum panel with Cytek’s new reagent family
Aug 17, 2020
Cytek Biosciences has already redefined what is possible in flow cytometry. The new Cytek cFluor family of reagents...
Applications of Hyperpolarized 129Xe MRI for functional imaging of the lungs
Aug 11, 2020
2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...
Detection of Rare Cells and Circulating Tumor Cells using NovoCyte flow cytometer
Aug 11, 2020
Circulating tumor cells (CTC) are rare cells shed from a solid tumor or metastases that circulate through the...
Introducing Amnis AI Image Analysis software
Aug 4, 2020
Amnis AI Image Analysis Software combines the power of high dimensional data reduction with artificial intelligence,...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
